OPK earnings date and last-quarter result: next report 2026-07-30, last quarter beat, P/E -4.29. Updated 2026-07-23.
OPKO Health (OPK) Research Hub
OPKO Health (OPK) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.63 USD (0.00%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.29, market cap 0.90B. This hub links to the full technical, earnings and options research available for OPK.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.63 USD (0.00%) |
| 52-week range | 1.17 USD – 1.77 USD |
| Trend regime | Range |
| 14-day RSI | 61.3 (Bullish) |
| Trailing P/E | -4.29 |
| Market cap | 0.90B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for OPK
Covered Call on OPK: how it works, illustrative setup around the real 1.63 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OPK: how it works, illustrative setup around the real 1.63 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OPK: how it works, illustrative setup around the real 1.63 USD price, max profit/loss, breakeven and when to use it. Educational.
OPK technical analysis: range, last 1.63 USD, RSI 61.3, 52w range 1.17 USD–1.77 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is OPK in?
OPKO Health (OPK) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is OPK in an uptrend or downtrend?
As of 2026-10-26, OPK is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OPK's trailing P/E ratio?
OPK's trailing P/E is -4.29, with a market cap of 0.90B. See the earnings research page for full valuation detail.
When does OPK next report earnings?
OPK is next scheduled to report earnings on 2026-07-30.